MedTrace Logo

Pain After Lung Cancer Surgery - Comparing Traditional Versus Prolonged Release Nerve Blockades

NCT05038007 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-09-21

No results posted yet for this study

Summary

To investigate the effect of liposomal bupivacaine compared with bupivacaine hydrochloride for intercostal blockades for patients undergoing Video-assisted thoracoscopic surgery.

Conditions

  • Postoperative Pain
  • Lung Cancer
  • Video Assisted Thoracoscopic Surgery
  • Blockades Neuromuscular
  • Anesthesia, Local

Interventions

DRUG

Liposomal bupivacaine

As prior described

DRUG

Bupivacaine Hydrochloride

As prior described

Sponsors & Collaborators

  • Jannie Bisgaard Stæhr

    lead OTHER

Principal Investigators

  • Jannie Bisgaard, MD, PhD · Aalborg University Hospital, department of Anaesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-15
Primary Completion
2022-04-01
Completion
2022-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05038007 on ClinicalTrials.gov